Connect with us

Hi, what are you looking for?

Economy

Cambodian PM gets AstraZeneca COVID-19 shot, defends Chinese vaccine

PHNOM PENH – Cambodian Prime Minister Hun Sen received on Thursday a shot of the AstraZeneca COVID-19 vaccine supplied by India, about three weeks into the launch of his country’s inoculation programme, which initially relied only on Chinese vaccines.

Mr. Hun Sen, 68, had vowed to be the first to receive the Sinopharm vaccine donated by China, but later said he was too old. His sons and the justice and environment ministers were among the first to get it instead.

China is one of Cambodia’s closest allies, and Hun Sen dismissed public hesitance about the safety of the Sinopharm vaccine.

“The Chinese vaccine has gone to more countries than the AstraZeneca vaccine, even countries that are allies of the West also use the Chinese vaccines,” Mr. Hun Sen told a news conference after getting his shot.

He urged people below 60 to get the Sinopharm vaccine and those older than 60 to receive the AstraZeneca vaccine.

The Southeast Asian nation of about 16 million has reported among the lowest number of coronavirus cases and no deaths, though last month saw a rise in cases that took the cumulative total detected to 909.

Cambodia received its first batch of 324,000 doses of the India-made AstraZeneca vaccine and supplied through the World Health Organization-backed COVAX vaccine-sharing programme on Tuesday.

India and China have been engaged in vaccine diplomacy to bolster their standing in the region, with both donating shipments to smaller and poor countries.

China’s first consignment of 600,000 doses of the Sinopharm vaccine had arrived in Phnom Penh on Feb. 7 and an additional 400,000 doses are set to arrive in April. – Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

The UK government will invest £100m in Britishvolt as the car battery manufacturing startup seeks to build Britain’s first large-scale “gigafactory” in the north-east...

Investing

Bankers and accountants are among those being summoned back to their offices after the government scrapped its work-from-home guidance in England with immediate effect....

Investing

The kitchens of Michelin-starred restaurants too often descend into alternative “moral universes” where bullies and bad behaviour thrive, a study has suggested. While Gordon...

Investing

A company controlled by the Duke of York and used to manage his investments is more than £200,000 in debt, according to newly filed...

Investing

Rogue waste collectors who fly-tip household rubbish will be targeted under a government crackdown. Fly-tipping increased sharply last year to 1.1 million cases in...

Investing

Peloton Interactive lost more than 25 per cent of its value on Wall Street at one point last night after the exercise bike maker...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.